Company / Operating Income per Share
West Pharmaceutical Services Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$8.09
FY2025
5-year range
$4.01 / $9.12
FY2021-FY2025
Trend
+4.3%
vs FY2024
Sector context
#27 of 154
Health Care
What the data says
West Pharmaceutical Services's operating income per share of $8.09 is higher than 82% of companies in the Health Care sector (FY2025). Operating Income per Share has fluctuated over the past 10 years, ranging from $2.52 in FY2016 to $9.12 in FY2023.
Based on SEC 10-K filings.
8.09 in FY2025 with a 5-year CAGR of +20.1%. Top quartile in the Health Care sector.
Declined from $9.12 to $8.09 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- +13.8%
- 5-Year CAGR
- +20.1%
- 10-Year CAGR
- -
Sector benchmark
+88.8% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 4.3% year-over-year.
- Ranks #27 out of 154 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2023.
- Lowest operating income per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.09 | +4.3% |
| FY2024 | $7.75 | -15.0% |
| FY2023 | $9.12 | +66.4% |
| FY2022 | $5.48 | +36.8% |
| FY2021 | $4.01 | +23.6% |
| FY2020 | $3.24 | -19.0% |
| FY2019 | $4.00 | +23.1% |
| FY2018 | $3.25 | +5.3% |
| FY2017 | $3.09 | +22.7% |
| FY2016 | $2.52 | +10.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026